Education
About Us
Working with TipRanks
Follow Us
Physiomics PLC (GB:PYC)
LSE:PYC
PYC Stock Chart & Stats
0.28 p
0.05 p(6.45%)
At close: 4:00 PM EST
0.28 p
0.05 p(6.45%)
Day’s Range― - ―
52-Week Range0.25 p - 0.80 p
Previous CloseN/A
Volume16.21M
Average Volume (3M)2.43M
Market Cap
£1.29M
Enterprise Value1.03M
Total Cash (Recent Filing)£257.00K
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.39
Next Earnings
Sep 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding303,208,700
10 Day Avg. Volume1,168,038
30 Day Avg. Volume2,434,740
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)1.60
Price to Sales (P/S)1.41
P/FCF Ratio-2.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Specialized Computational Drug-modelling ServicesPhysiomics delivers specialized quantitative modelling and simulation services that translate biology and pharmacology into actionable decisions for pharma clients. That technical niche creates high switching costs, consultative relationships and structural demand from R&D budgets, supporting durable contract opportunities.
Strong Recent Revenue ReboundA material revenue rebound signals improving market adoption of services and stronger sales pipeline execution. If sustained, rising top-line can leverage fixed-cost modelling expertise to improve operating leverage, making future margin expansion and self-funding more achievable over several quarters.
Debt-free, Low-leverage Balance SheetA debt-free capital structure provides financial flexibility and lower interest burden, reducing refinancing risk. For a services business with lumpy contracts, low leverage preserves optionality to raise equity or invest in growth without debt covenants, supporting resilience during uneven cash flows.
Bears Say
Persistent Losses And Weak MarginsDespite top-line recovery, the firm continues to report net losses and deeply negative margins. Ongoing unprofitability erodes shareholder value and indicates the business has not yet converted client demand into sustainable, profitable delivery; long-term viability depends on margin improvement.
Recurring Cash BurnConsistent negative operating and free cash flow creates funding pressure and increases dependency on external capital. Persistent cash burn constrains reinvestment in sales and capability building, elevates dilution risk if equity raises are required, and weakens resilience to contract variability.
Small Equity Base And High Negative ROEA limited equity cushion combined with very negative ROE implies losses materially dilute shareholder capital. With modest assets and thin reserves, the company faces heightened refinancing and dilution risk if profitability and cash generation do not improve, restricting strategic flexibility.
Physiomics News
PYC FAQ
What was Physiomics PLC’s price range in the past 12 months?
Physiomics PLC lowest share price was 0.25 p and its highest was 0.80 p in the past 12 months.
What is Physiomics PLC’s market cap?
Physiomics PLC’s market cap is £1.29M.
When is Physiomics PLC’s upcoming earnings report date?
Physiomics PLC’s upcoming earnings report date is Sep 24, 2026 which is in 189 days.
How were Physiomics PLC’s earnings last quarter?
Physiomics PLC released its earnings results on Feb 16, 2026. The company reported -0.001 p earnings per share for the quarter, missing the consensus estimate of N/A by -0.001 p.
Is Physiomics PLC overvalued?
According to Wall Street analysts Physiomics PLC’s price is currently Overvalued.
Does Physiomics PLC pay dividends?
Physiomics PLC does not currently pay dividends.
What is Physiomics PLC’s EPS estimate?
Physiomics PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Physiomics PLC have?
Physiomics PLC has 303,208,700 shares outstanding.
What happened to Physiomics PLC’s price movement after its last earnings report?
Physiomics PLC reported an EPS of -0.001 p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -15.385%.
Which hedge fund is a major shareholder of Physiomics PLC?
Currently, no hedge funds are holding shares in GB:PYC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Physiomics PLC
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union. It offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. The company also develops technology for use in the field of personalized medicine. Physiomics Plc was incorporated in 2001 and is based in Oxford, the United Kingdom.